A new model to determine Optimal Exposure to Tacrolimus and Mycophenolate Mofetil after renal transplantation

Pankewycz, Oleh; ONAN, ENGİN; Rucker, Dane; Wang, Dongliang; Gruessner, Angelika; Gruessner, Rainer; Laftavi, Mark

doi:10.1111/ctr.13893

A new model to determine Optimal Exposure to Tacrolimus and Mycophenolate Mofetil after renal transplantation

Pankewycz O., ONAN E., Rucker D., Wang D., Gruessner A., Gruessner R., ...Daha Fazla

CLINICAL TRANSPLANTATION, cilt.34, sa.7, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 34 Sayı: 7
Basım Tarihi: 2020
Doi Numarası: 10.1111/ctr.13893
Dergi Adı: CLINICAL TRANSPLANTATION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE
Çukurova Üniversitesi Adresli: Evet

Özet

Background Drug dosing for Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) after kidney transplantation remains challenging. Therapeutic drug monitoring (TDM) offers a means to individualize drug dosing and improve outcomes.